Articles
Device ad-vice: Best practices for handling a medical device recall

Device ad-vice: Best practices for handling a medical device...

In part 2 of the "Device ad-vice" series, Amy Smith offers advice for best practices on dealing with medical device recalls. Product recalls are a major headache for pharma, but device manufacturers can feel the pain, too. In the U.S., the FDA's 510(k) process for...

Articles
Key lessons on royalties too often learned the hard way

Key lessons on royalties too often learned the hard way

Nigel Borshell offers his top tips in understanding effective royalty rates. The pharmaceutical and biotechnology industry is undergoing considerable change as the patent cliff looms, fostering invention and...

Articles
A response to closing the Psoriasis 360 facebook page

A response to closing the Psoriasis 360 facebook page

Due to many questions about the closure of the Psoriasis 360 page, former Janssen employee Alex Butler provides his response and thoughts on where pharma goes from here. As a former employee of Janssen, I am publically linked to the Psoriasis 360 facebook page, so the announcement of its withdrawal has sparked a large number of…

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more